Casdin Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Casdin Capital’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$837K	Hold
2025 Q1	$875K	Hold
2024 Q4	$1.12M	Buy
2022 Q2	–	Sell
2022 Q1	$3.92M	Hold
2021 Q4	$9.39M	Hold
2021 Q3	$12.6M	Hold
2021 Q2	$20M	Buy